SecBot SecBot
Home › SEC Filings › Current Report (8-K)

Current Report (8-K)

10,000+ reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
ATKR8-Kbullish7/10Prysmian S.p.A. completed its acquisition of Atkore Inc. on October 19, 2026, for $95.00 per share in cash, totaling appOct 19, 2026
EOSE8-Kmixed5/10Eos Energy Enterprises released preliminary Q3 2026 results showing revenue of $82M-$83M (169-172% YoY growth) and a GAAOct 19, 2026
AASP8-Kneutral5/10Agassi Sports Entertainment Corp. raised $1.825M through a private placement and converted a $1M related-party note intoOct 19, 2026
FUL8-Kneutral5/10H.B. Fuller's Board unanimously rejected Ancora Holdings Group's second unsolicited, non-binding proposal to acquire theOct 19, 2026
MKSI8-Kbullish6/10MKS Inc. announced it has entered into a definitive agreement to sell its Ophir Optics business to TTM Technologies, IncOct 19, 2026
TMS8-Kbullish6/10Teamshares Inc. entered into a $130 million senior secured term loan facility with Sound Point Capital affiliates, usingOct 19, 2026
TTMI8-Kbullish6/10TTM Technologies announced a definitive agreement to acquire the Ophir Optics business from MKS Inc. for approximately $Oct 19, 2026
DFDV8-Kneutral3/10DeFi Development Corp. reported a modest weekly increase of 3,983 SOL and SOL equivalents, bringing total holdings to apOct 19, 2026
CJMB8-Kneutral4/10Callan JMB Inc. terminated its previously announced Asset Purchase and Sale Agreement to acquire a 50% interest in certaOct 19, 2026
EXE8-Kneutral3/10Expand Energy appointed Daniel E. Brown as President and CEO, effective October 26, 2026, replacing interim CEO Michael Oct 19, 2026
AVBP8-Kbullish6/10ArriVent BioPharma announced the publication of Phase 1b (FURMO-002) results for firmonertinib in EGFR PACC-mutant NSCLCOct 19, 2026
MAT8-Kneutral3/10Mattel announced the appointment of Peter Griffith as CFO and board director, effective October 20, 2026, succeeding PauOct 19, 2026
SLN8-Kbullish9/10Silence Therapeutics plc has entered into a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany in an Oct 19, 2026
CLNN8-Kbullish7/10Clene Inc. announced it has submitted a New Drug Application (NDA) to the FDA seeking accelerated approval of CNM-Au8 foOct 19, 2026
DX8-Kbearish6/10Dynex Capital reported Q3 2026 results showing a sharp decline in book value per common share to $10.91 from $12.90 in QOct 19, 2026
CRMD8-Kbullish7/10CorMedix announced that the FDA has accepted for filing and granted Priority Review to its supplemental New Drug ApplicaOct 19, 2026
MSTR8-Kneutral4/10Strategy Inc disclosed weekly ATM activity, bitcoin purchases, and a board-approved increase in its digital credit securOct 19, 2026
SLE8-Kbullish7/10Stockholders approved all proposals related to Metaplanet's strategic investment, including the issuance of up to 435,85Oct 19, 2026
ASST8-Kmixed5/10Strive, Inc. disclosed the purchase of 4,045 bitcoin for ~$335M at an average price of ~$82,803, funded by warrant exercOct 19, 2026
LEU8-Kbullish6/10Centrus Energy Corp. acquired 100% of Westerman Holdings, LLC, a key centrifuge component supplier and industrial fabricOct 19, 2026
SLGN8-Kbullish7/10Silgan Holdings announced a transformative transaction to contribute its Metal Containers and Food & Beverage Flat Cap COct 19, 2026
NWSA8-Kneutral2/10News Corp filed an 8-K to disclose daily buy-back notifications provided to the ASX under its existing $1 billion repurcOct 19, 2026
EQPT8-Kbullish6/10EquipmentShare raised its full-year 2026 guidance, increasing midpoint total revenue outlook to ~$5.927B from ~$5.468B (Oct 19, 2026
MRKR8-Kbullish5/10Marker Therapeutics announced it was awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials Grants Oct 19, 2026
IRON8-Kbullish7/10Disc Medicine announced positive topline results from the pivotal Phase 3 APOLLO trial of bitopertin in erythropoietic pOct 19, 2026
EYPT8-Kbearish7/10EyePoint announced that LUCIA, the second pivotal Phase 3 trial of DURAVYU in wet AMD, failed to meet its primary endpoiOct 19, 2026
CBZ8-Kneutral4/10CBIZ reported Q3 2026 revenue of $702M (+1.2% YoY) and GAAP EPS of $0.79 (+64.6% YoY), with Adjusted EBITDA of $132M (+6Oct 19, 2026
REKR8-Kbearish7/10Rekor Systems filed a verified complaint in Delaware Chancery Court against former director Viraj Mehta, alleging he breOct 19, 2026
CLF8-Kbullish7/10Cleveland-Cliffs reported Q3 2026 GAAP net income of $165M ($0.26 diluted) vs. a net loss of $134M in Q2 2026, with reveOct 19, 2026
JEF8-Kneutral4/10Jefferies Financial Group held its 2026 Investor Meeting on October 19, 2026, posting a comprehensive investor presentatOct 19, 2026
« Previous Page 81 of 334 Next »